Zotarolimus eluting stent Drug eluting stent
systematic review meta-analysis network meta-analysis
 

Medtronic Endeavour - Endeavour      

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathmyocardial infarction (fatal and non fatal)

acute myocardial infarction  

ZEST AMI (vs PES), 2009      NCTzotarolimus eluting stentpaclitaxel eluting stentRisk of bias negative∞%
ZEST AMI (vs SES), 2009      NCTzotarolimus eluting stentsirolimus eluting stentnegative-24%-100%

coronary artery disease  

ENDEAVOR II, 2006   zotarolimus eluting stentbare-metal stentLow risk of bias suggesting
RESOLUTE All comers, 2010        NCTzotarolimus eluting stenteverolimus eluting stentRisk of bias negative-41%3%
TWENTE, 2012      NCTzotarolimus eluting stenteverolimus eluting stent click to display paper's table" > -
ENDEAVOR IV, 2009        NCTzotarolimus eluting stentpaclitaxel eluting stentRisk of bias suggesting-9%-56%
ZEST AMI (vs PES), 2009      NCTzotarolimus eluting stentpaclitaxel eluting stentRisk of bias negative∞%
ZoMaxx I, 2008     zotarolimus eluting stentpaclitaxel eluting stent -
ZEST (vs PES), 2009    NCTzotarolimus eluting stentpaclitaxel eluting stentsuggesting-40%-24%
ENDEAVOR III, 2006        NCTzotarolimus eluting stentsirolimus eluting stentsuggesting -30%-82%
PROTECT, 2012    NCTzotarolimus eluting stentsirolimus eluting stentRisk of bias -
ZEST (vs SES), 2009    NCTzotarolimus eluting stentsirolimus eluting stentRisk of bias negative-15%-15%
ZEST AMI (vs SES), 2009      NCTzotarolimus eluting stentsirolimus eluting stentnegative-24%-100%
SORT-OUT-3, 2010      NCTzotarolimus eluting stentsirolimus eluting stentRisk of bias negative 45%247%

stable angina  

ENDEAVOR II, 2006   zotarolimus eluting stentbare-metal stentLow risk of bias suggesting
RESOLUTE All comers, 2010        NCTzotarolimus eluting stenteverolimus eluting stentRisk of bias negative-41%3%
ENDEAVOR IV, 2009        NCTzotarolimus eluting stentpaclitaxel eluting stentRisk of bias suggesting-9%-56%
ENDEAVOR III, 2006        NCTzotarolimus eluting stentsirolimus eluting stentsuggesting -30%-82%
PROTECT, 2012    NCTzotarolimus eluting stentsirolimus eluting stentRisk of bias -
ZEST (vs SES), 2009    NCTzotarolimus eluting stentsirolimus eluting stentRisk of bias negative-15%-15%



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons